A Randomized Phase III Study of TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer
Phase of Trial: Phase III
Latest Information Update: 17 Jul 2015
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms TRAIL
- 13 Jul 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
- 20 Apr 2015 Status changed from recruiting to completed.
- 30 Jan 2013 Planned number of patients changed from 562 to 276 as reported by ClinicalTrials.gov.